BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 38542439)

  • 1. Long Non-Coding RNA-Cardiac-Inducing RNA 6 Mediates Repair of Infarcted Hearts by Inducing Mesenchymal Stem Cell Differentiation into Cardiogenic Cells through Cyclin-Dependent Kinase 1.
    Cui X; Dong H; Luo S; Zhuang B; Li Y; Zhong C; Ma Y; Hong L
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin enhances the therapeutic efficacy of mesenchymal stem cells-derived exosomes in acute myocardial infarction via up-regulating long non-coding RNA H19.
    Huang P; Wang L; Li Q; Tian X; Xu J; Xu J; Xiong Y; Chen G; Qian H; Jin C; Yu Y; Cheng K; Qian L; Yang Y
    Cardiovasc Res; 2020 Feb; 116(2):353-367. PubMed ID: 31119268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA Braveheart promotes cardiogenic differentiation of mesenchymal stem cells in vitro.
    Hou J; Long H; Zhou C; Zheng S; Wu H; Guo T; Wu Q; Zhong T; Wang T
    Stem Cell Res Ther; 2017 Jan; 8(1):4. PubMed ID: 28095922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction.
    Lu D; Liao Y; Zhu SH; Chen QC; Xie DM; Liao JJ; Feng X; Jiang MH; He W
    Stem Cell Res Ther; 2019 Apr; 10(1):127. PubMed ID: 31029167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
    Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
    Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nesprin-1 has key roles in the process of mesenchymal stem cell differentiation into cardiomyocyte-like cells in vivo and in vitro.
    Yang W; Zheng H; Wang Y; Lian F; Hu Z; Xue S
    Mol Med Rep; 2015 Jan; 11(1):133-42. PubMed ID: 25339194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractional Flow Reserve-Based Patient Risk Classification.
    Stanojević Pirković M; Pavić O; Filipović F; Saveljić I; Geroski T; Exarchos T; Filipović N
    Diagnostics (Basel); 2023 Oct; 13(21):. PubMed ID: 37958245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research Progress on Cardiac Tissue Construction of Mesenchymal Stem Cells for Myocardial Infarction.
    Yang GD; Ma DS; Ma CY; Bai Y
    Curr Stem Cell Res Ther; 2024; 19(7):942-958. PubMed ID: 37612870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of bone marrow mesenchymal stem cell-derived exosomes on cardiomyoblast hypoxia-reperfusion injury through the HAND2-AS1/miR-17-5p/Mfn2 axis.
    Li Q; Bu Y; Shao H; Li W; Zhao D; Wang J
    BMC Cardiovasc Disord; 2023 Mar; 23(1):114. PubMed ID: 36882677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDK1 bridges NF-κB and β-catenin signaling in response to H. pylori infection in gastric tumorigenesis.
    Zhu S; Al-Mathkour M; Cao L; Khalafi S; Chen Z; Poveda J; Peng D; Lu H; Soutto M; Hu T; McDonald OG; Zaika A; El-Rifai W
    Cell Rep; 2023 Jan; 42(1):112005. PubMed ID: 36681899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pluripotent Stem Cells in Clinical Cell Transplantation: Focusing on Induced Pluripotent Stem Cell-Derived RPE Cell Therapy in Age-Related Macular Degeneration.
    Yang YP; Hsiao YJ; Chang KJ; Foustine S; Ko YL; Tsai YC; Tai HY; Ko YC; Chiou SH; Lin TC; Chen SJ; Chien Y; Hwang DK
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation in myocardial infarction: roles of mesenchymal stem cells and their secretome.
    Shao L; Shen Y; Ren C; Kobayashi S; Asahara T; Yang J
    Cell Death Discov; 2022 Nov; 8(1):452. PubMed ID: 36351896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of mesenchymal stem cells for prevention of acute myocardial infarction induced heart failure: study protocol of a phase III randomized clinical trial (Prevent-TAHA8).
    Attar A; Monabati A; Montaseri M; Vosough M; Hosseini SA; Kojouri J; Abdi-Ardekani A; Izadpanah P; Azarpira N; Pouladfar G; Ramzi M
    Trials; 2022 Aug; 23(1):632. PubMed ID: 35927674
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.